Pillar of Japan's Growth Strategy: "Synthetic Biology & Bio" - Accumulation of Next-Generation Technologies for Decarbonization and Industrial Competitiveness

RX Japan LLC (Headquarters: Chuo-ku, Tokyo; Representative Executive Officer and President: Takeshi Tanaka) will hold "Interphex Week Tokyo / Regenerative Medicine Expo Tokyo" at Makuhari Messe for three days from May 20 (Wednesday) to 22 (Friday), 2026.

In recent years, the government has positioned the bioeconomy as a core of "new capitalism" and is accelerating investment in the bio-manufacturing field, including synthetic biology. In addition, from the perspective of GX (Green Transformation), there is a growing movement to shift from conventional petroleum-derived processes to bio-derived ones, and biotechnology is attracting attention as a key to achieving both decarbonization and industrial competitiveness. Furthermore, amidst increasing uncertainty surrounding the supply chains for pharmaceuticals and raw materials, the establishment of manufacturing bases and domestic repatriation in the bio field are gaining importance from the perspective of economic security. The perspective of "how to stably manufacture and supply" is becoming a factor that will determine future industrial competitiveness, not just research and development. Against this backdrop, this exhibition will bring together companies and research institutions at the forefront of bio-manufacturing, including synthetic biology, biopharmaceuticals, and contract development and manufacturing organizations (CDMO).

Next-Generation Industrial Structure Pioneered by Bio x Manufacturing

In this field, advances in biotechnology are driving a shift towards an industrial structure that integrates "research" to "manufacturing" and "supply." At the venue, in addition to research and development areas such as Takara Bio Inc. and LIVIUS JAPAN Co., Ltd., manufacturing process technologies by Asahi Kasei Life Science Corporation, and companies responsible for supply and infrastructure areas such as Kaneka Corporation and Eppendorf Co., Ltd. will exhibit. This allows for an overview of the next-generation industrial structure, including not only "research and development" of biopharmaceuticals and regenerative medicine, but also the perspective of "how to stably manufacture and deliver."

Exhibited Products and Services <Partial Excerpt>

This exhibition will bring together technologies that support each area of the bio-industry: "Research and Development," "Manufacturing," and "Supply and Infrastructure."

【Research and Development Area】

GMP Manufacturing of Cell Preparations

We provide various cell preparation manufacturing services based on reliable technology developed through the development of gene-modified T lymphocyte therapies such as TCR (T cell receptor) gene therapy and CAR (chimeric antigen receptor) gene therapy, and clinical trial achievements. We also have various know-how using Takara Bio's gene transfer enhancer RetroNectin, and have multiple achievements in closed-system cell culture. [Exhibitor: Takara Bio Inc.]

Hair Growth Reagent Aiming to Improve Hair Follicle Cell Environment by Applying Proprietary miRNA Technology

This is a hair growth reagent that aims to improve the hair follicle cell environment by applying proprietary miRNA technology. It approaches the hair cycle from the perspective of activating cell function and pursues a mechanism of action different from existing treatments. An example of applying cell function improvement technology in the field of regenerative medicine. [Exhibitor: LIVIUS JAPAN Co., Ltd.]

【Manufacturing and Process Area】

Virus Removal Related Equipment

We are committed to solving challenges in the safety, efficiency, and purity of therapeutic drugs in the pharmaceutical and bioprocess industries. By utilizing technology platforms such as oligonucleotide synthesis, inline buffer preparation, chromatography, and bioprocess filtration, we develop cutting-edge and elaborately manufactured equipment that innovates the future of pharmaceutical manufacturing together with our customers.

[Exhibitor: Asahi Kasei Life Science Corporation]

【Supply and Infrastructure Area】

Environmentally Friendly Sustainable "BioBased" Consumables (Tips, Tubes, Plates)

These are environmentally friendly "BioBased" consumables made from sustainable raw materials produced from edible oil residues, etc., reducing the use of fossil fuels. Using these contributes to sustainability. The lineup includes pipette tips, tubes, and PCR plates.

[Exhibitor: Eppendorf Co., Ltd.]

Constant Temperature Transport Package "TACPack®"

TACPack® is a constant temperature transport package that can maintain a constant temperature for a long time by combining phase change materials such as "Passamo" and insulation containers designed and manufactured in-house. In addition, products are exhibited by temperature range (-65℃ to +37℃) and application (domestic, international, etc.).

[Exhibitor: Kaneka Corporation]

Event Outline

Interphex Week Tokyo / Regenerative Medicine Expo Tokyo

・Dates: May 20 (Wednesday) - 22 (Friday), 2026, 10:00 - 17:00

・Venue: Makuhari Messe Halls 1-8

・Organizer: RX Japan LLC

・Interphex Week Constituent Exhibitions: Interphex Japan / in-Pharma Japan / Bio-Pharmaceutical Expo / PharmaLab Expo / Pharma DX